Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: IntellaSys’ 40-core Processor..Jldmt & meta

I tend to agree with both of you...yes, will we see more licensing, and yes, if and when the patents are issued that reexamination certificate, we will see a bounce. That bounce will be short-lived IMO if the following weeks and months do not show licenses with more rapidity and more $$$$ attached too.

I still go back to the RG presentation charts that show a 1/3 to 2/3 ratio on future revenue when he compares licensing to new business ventures. I would speculate that if any of us were able to be present during one of the PTSC promotional sessions that, in that presentation would be some sort of dislcosure of licensing being reduced greatly as compared to what we all once thought was coming in within the next 4-8 quarters.

Is that all bad????....NO...but the new ventures will have to be profitable a lot sooner with robust earnings being reported for that same 4-8 quarter time period for us to eventually get off this BB and get some decent PPS...If not, we will languish here ,except for that bounce we could get from the PTO, for a lot longer thatn may of us had hoped for.

JMHO

JMHO

Share
New Message
Please login to post a reply